The death of an Italian teenager from thrombosis led to the fact that the drug Vaxzevria will be used only on citizens over 60 years of age.
The Italian authorities have approved a combination of coronavirus vaccines-this will allow those who have already received the first dose of the drug Vaxzevria, developed by AstraZeneca, to receive a second dose of another vaccine.
This was reported by the Italian Medicines Agency (AIFA).
вЂњBased on clinical studies published over the past few weeks, the AIFA Scientific and technical committee have decided to approve the vaccine mix,вЂќ the agency said in a statement.
Thus, Italians who were vaccinated by AstraZeneca will be offered a second dose in 8-12 weeks to take another mRNA-based vaccine вЂ” that is, drugs from Moderna or Pfizer.
This decision will apply only to citizens under 60 years of age. It was taken after the death of a teenager who received the AstraZeneca vaccine. He was diagnosed with a rare form of thrombosis, and the authorities allowed the use of the drug only among people over 60 years of age.
Earlier, the Norwegian Cabinet of Ministers officially banned the use of the coronavirus vaccine developed by the University of Oxford and AstraZeneca.
We also wrote that in Canada, too, it was allowed to interchangeably combine COVID-vaccines from AstraZeneca/Oxford, Pfizer/BioNTech, or Moderna.